Guideline-based medications for older adults discharged after percutaneous coronary intervention in a suburban city of Japan: A cohort study using claims data

Medicine & Life Sciences

• Percutaneous Coronary Intervention 68%
• Prescriptions 58%
• Japan 57%
• Secondary Prevention 50%
• Hydroxymethylglutaryl-CoA Reductase Inhibitors 50%
• Cohort Studies 47%
• Guidelines 44%
• Angiotensin Receptor Antagonists 38%
• Angiotensin-Converting Enzyme Inhibitors 34%
• Odds Ratio 33%
• Confidence Intervals 30%
• Retrospective Studies 11%
• Regression Analysis 11%
• Logistic Models 11%
• Population 6%

Chemical Compounds

• Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor 100%
• Percutaneous 96%
• Receptor Blocking Agent 74%
• Angiotensin-Converting Enzyme Inhibitor 63%
• Anticoagulant Agent 59%
• Angiotensin II 58%